Quantifying the massive pleiotropy of microRNA: a human microRNA-disease causal association database generated with

K Rowan Wang1, Julian Hecker1,2, Michael J McGeachie2

  • 1Harvard University, Cambridge, MA, 02138, USA.

Insights

MicroRNAs (miRNAs) regulate many diseases, but their multiple roles (pleiotropy) are unclear. This study quantifies miRNA pleiotropy using AI, revealing key characteristics and creating a valuable disease database for researchers.

Area of Science:

  • Genetics and Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • MicroRNAs (miRNAs) are crucial regulators in human diseases.
  • The phenomenon of miRNA pleiotropy, where one miRNA affects multiple diseases, is biologically significant but poorly understood.
  • Quantifying miRNA pleiotropy is essential for understanding their broad roles in health and disease.

Purpose of the Study:

  • To systematically quantify miRNA pleiotropy.
  • To identify biological and bioinformatic characteristics associated with increased miRNA pleiotropy.
  • To develop a comprehensive database of human miRNA-disease causal associations using artificial intelligence.

Main Methods:

  • Development of the miRNA Artificial Intelligence Disease Database (miRAIDD) utilizing large language models (LLM).
  • Systematic quantification of miRNA pleiotropy based on curated miRNA-disease associations.
  • Analysis of biological and bioinformatic features of miRNAs to correlate with pleiotropy.

Main Results:

  • Successful quantification of miRNA pleiotropy, highlighting its translational importance.
  • Identification of specific miRNA characteristics linked to higher pleiotropic activity.
  • Creation and release of the miRAIDD database, providing a valuable resource for the research community.

Conclusions:

  • The study provides a quantitative framework for understanding miRNA pleiotropy.
  • Specific miRNA features can predict their involvement in multiple diseases.
  • The miRAIDD database and associated AI methodologies offer significant advancements for miRNA research in human diseases.